Medical

HOUSTON, Texas -- Celestial Skin International announces their corporate addition of LipoDissolve, a non-surgical, cosmetic, medical treatment that has been proven to eliminate unwanted fat for good. Seymour M. Weaver, III, M.D., founder of Celestial Skin, an aesthetic treatment center, has clearly earned his reputation as one of Houston's most-respected cosmetic dermatologists and surgeons, by providing breakthrough treatments and educating patients and physicians, alike.

REDONDO BEACH, Calif. -- DermHair Clinic, a division of FineTouch Dermatology, Inc., located in Redondo Beach, Calif., offers a unique hair-restoration procedure called "Body Hair Transplantation" (BHT) where body hair is transplanted to balding areas on the head.

MIDDLETOWN, Ohio -- Parent Project Muscular Dystrophy (PPMD), the largest grassroots organization in the U.S. that is entirely focused on Duchenne muscular dystrophy (DMD), announced today the hiring of Dr. Giovanna M. Spinella as its medical director and its plans to create a systematic approach to the clinical management of boys with DMD.

SAN MARINO, Calif. and MANILA, Philippines -- Epeius Biotechnologies today announced the publication of clinical data from studies conducted at the University of the Philippines, Asian Hospital and Medical Center, Makati Medical Center, Manila, Philippines and Lutheran Medical Center, New York, USA, revealing the safety and single agent efficacy of Rexin-G(TM) for the treatment of a broad spectrum of chemotherapy-resistant cancers.

LOS ANGELES, Calif. -- MediQuin Credentialing Services, Inc. currently serves the medical community by providing credentialing and automated-application processing. By outsourcing, the company allows their clients to focus on successfully growing their practices.

MECHELEN, Belgium -- Responding to the need to make timely evaluations and decisions when treating treatment experienced HIV patients, Virco Labs (www.vircolab.com), a leader in drug resistance testing recently introduced an improved virco(R)TYPE HIV-1 test that rapidly determines the complex phenotypic resistance profiles for darunavir, tipranavir and other antiretroviral (ARV) drugs.

SAN MARINO, Calif. -- Epeius Biotechnologies Corporation today announced that Dr. Frederick Hall, President and CEO of Epeius Biotechnologies, has accepted an invitation to speak at the upcoming Global Pharmaceutical Research & Development Summit held on Oct. 24 at 4:10 p.m. (PT) in Anaheim, Calif. Dr. Hall will present the current status of global development and the broad pharmaceutical indications for the company's innovative targeting technology platform.

SARASOTA, Fla. -- The First Annual Sino-American Inter-University Medical/Dental/Nursing Exchange Conference will be held at the campus of Lake Erie College of Osteopathic Medicine, it was announced today by L.R. Mage, LLC, the USA event administrator. The event will be open to the entire healthcare community October 14, 2006 from 9:00 A.M. to 3:00 P.M.

LOS ANGELES, Calif. -- The Sher Institute for Reproductive Medicine(SM) - Los Angeles (SIRM-LA) is proud to announce the appointment of Dr. Rudy Quintero as an Associate Medical Director of the practice. A graduate of the UCLA School of Medicine, Dr. Quintero completed his residency at Glendale Adventist Hospital and a fellowship in Reproductive Endocrinology and Infertility at Stanford University Medical Center.

SAN FRANCISCO, Calif. -- Robert P. "Skip" Cummins, chairman and CEO of Cyberonics Inc., will keynote the 2006 Neurotech Leaders Forum, to be held September 28-29, 2006 at the Crowne Plaza San Francisco International Airport. The free-speaking neurotechnology industry pioneer will share some of his experiences dealing with regulatory, technical, and marketing issues during his tenure at Cyberonics.